MI
MREO

Markowski Investments’s Mereo BioPharma MREO Stock Holding History

Markowski Investments’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$477 Buy
+1,500
New +$450 ﹤0.01% 594

Other funds holding MREO

TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $18.2B AUM 21.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJBC
James J. Burns & Company Melville, New York $924M AUM 22.18% 1-Year Est. Return
JF
JMN Financial New Albany, Ohio $129M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Markowski Investments's MREO Position: Q2 2026 in Review

Markowski Investments opened a new position in Mereo BioPharma (MREO) in Q2 2026: 1,500 shares worth $477. The stake represents ﹤0.01% of the portfolio and ranks #594 among its holdings.

38 funds tracked by Wall St. Rank hold MREO as of Q2 2026.

  • Markowski Investments held 1,500 shares of Mereo BioPharma worth $477 as of Q2 2026.
  • Mereo BioPharma was a new Markowski Investments position in Q2 2026.
  • Mereo BioPharma made up ﹤0.01% of Markowski Investments's portfolio in Q2 2026, its #594 holding.
  • 38 funds tracked by Wall St. Rank held Mereo BioPharma as of Q2 2026.

Based on Markowski Investments's 13F filing for Q2 2026, filed 13 Aug 2026.